drugset / Trial / NCT03066245

Use of Stem Cells Cultured on a Scaffold for the Treatment of Aneurysmal Bone Cysts (ABC)

NCT03066245 ↗

Phase 1/2 Unknown 4 enrolled Sophia Al-Adwan
NaSingle-groupOpen-labelTreatment

Summary

Patients qualified for this study are those diagnosed with ABCs and failed to be treated with other forms of classical therapies. In which, these patients will be engrafted with biodegradable scaffolds seeded with Mesenchymal Stem Cells (MSCs) supplemented with Platelet lysate.

Timeline

Start
2018-05-03
Primary completion
2019-12
Completion
2020-03

Drugs

EvaluationDrugModalityDoseRoute
Subject MSC-PLGA Unknown 1e+06 cells Other

Indications